XTL BIOPHARMACEUTICALS LTD.
XTL Biopharmaceuticals Ltd is a clinical-stage biotech company focused on the development of pharmaceutical products for the treatment of autoimmune diseases including lupus. The Company’s lead drug candidate, hCDR1, is a world-class clinical asset for the treatment of systemic lupus erythematosus (SLE). Treatments currently on the market for SLE are not effective enough for most patients and some have significant side effects. Robust clinical data on hCDR1 has been produced in three clinical trials with 400 patients and over 200 preclinical studies with data published in more than 40 peer reviewed scientific journals.
XTL BIOPHARMACEUTICALS LTD.
Industry:
Biotechnology Developer Platform Pharmaceutical
Founded:
1993-01-01
Address:
Herzliya, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.xtlbio.com
Total Employee:
1+
Status:
Active
Contact:
+972 9-955-7080
Email Addresses:
[email protected]
Total Funding:
2.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Microsoft Exchange Online PHP
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.xtlbio.com Semrush global rank: 5.94 M Semrush visits lastest month: 1.39 K
- Host name: 104.21.64.1
- IP address: 104.21.64.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "XTL Biopharmaceuticals Ltd."
About Us - XTLbio
XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the …See details»
Executive Management | XTLbio
Shlomo Shalev joined our Board of Directors in December 2014 and was appointed Chief Executive Officer in May, 2020.Most recently served as Chairman of the Board of Micronet, a TASE listed company. In addition to …See details»
XTL Biopharmaceuticals Ltd. - Crunchbase Company Profile
Sub-Organization of . Yeda Research and Development Co. Ltd . Founded Date 1993; Operating Status ... Company Type For Profit; Contact Email [email protected]; Phone Number +972 9 …See details»
Company Description - Stock Analysis
Dec 5, 2024 Company profile for XTL Biopharmaceuticals Ltd. (XTLB) with a description, list of executives, contact details and other key facts.See details»
XTL Biopharmaceuticals Company Description - Stock Analysis
Dec 5, 2024 Company profile for XTL Biopharmaceuticals Ltd. (TLV: XTLB) with a description, list of executives, contact details and other key facts.See details»
Xtl Biopharma ADR (XTLB-Q) Profile - The Globe and Mail
See the company profile for Xtl Biopharma ADR (XTLB-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
XTL Biopharmaceuticals Company Profile | Management and
[email protected]: 6: first_last: [email protected]: 7: last: [email protected]: Your Questions, Our Answers Get Free Access to XTL Biopharmaceuticals Contacts Info. What is …See details»
XTL Biopharmaceuticals Ltd. - Drug pipelines, Patents, Clinical trials ...
For further information, please contact: Investor Relations, XTL Biopharmaceuticals Ltd.Tel: +972 3 611 6666Email: [email protected] Cautionary Statement This disclosure may …See details»
Directors | XTLbio
Shlomo Shalev serves as a director in our company since December 2014, and starting September 2015 serves as the company's Chairman. most recently served as Chairman of the …See details»
XTL Biopharmaceuticals - Craft
See insights on XTL Biopharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
XTL Biopharmaceuticals Confirms that it has not Experienced any ...
Ramat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical stage biopharmaceutical …See details»
XTL Biopharmaceuticals - Products, Competitors, Financials, …
In parallel, the Company is actively looking to expand and identify additional assets to add to XTL's portfolio. XTL is traded on the Nasdaq Capital Market (NASDAQ: XTLB) and the Tel …See details»
XTL Biopharmaceuticals Confirms that it has not Experienced
Oct 20, 2023 XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelSee details»
Corporate Governance | XTLbio
Election of Directors and Terms of Office Our Board of Directors currently consists of seven members, including our non-executive Chairman. Other than our two external directors, our …See details»
XTL Biopharmaceuticals Ltd. (XTLB) - Yahoo Finance
Find the latest XTL Biopharmaceuticals Ltd. (XTLB) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
XTL Biopharmaceuticals Ltd. (XTLB) - Stock Analysis
1 day ago XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million. expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company …See details»
Investors - XTLbio
Established in 1993, XTL became a public company in 2000. XTL's ADRs (1:20 ratio) are publicly traded on the NASDAQ and its shares are traded on the Tel Aviv Stock Exchange (NASDAQ: …See details»
XTLBio - Facebook
XTLBio. 574 likes. XTL Bio focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical...See details»
Products Pipeline - XTLbio
The XTLbio pipeline is generated by systematically identifying, validating and in-licensing therapeutic candidates with advantages over current therapies and which address unmet …See details»